Schonfeld Strategic Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,066,072
-16.6%
23,064
-20.7%
0.02%
-23.8%
Q2 2023$2,477,574
-59.3%
29,100
-60.5%
0.02%
-63.8%
Q1 2023$6,094,620
-19.1%
73,651
-23.1%
0.06%
-7.9%
Q4 2022$7,536,322
+396.5%
95,821
+367.4%
0.06%
+384.6%
Q3 2022$1,518,000
+406.0%
20,500
+659.3%
0.01%
+225.0%
Q1 2021$300,000
-15.7%
2,700
-10.0%
0.00%
-20.0%
Q4 2020$356,000
-92.7%
3,000
-94.6%
0.01%
-94.6%
Q3 2020$4,882,000
+79.2%
55,945
+83.9%
0.09%
+158.3%
Q2 2020$2,724,000
+912.6%
30,422
+1026.7%
0.04%
+111.8%
Q1 2020$269,000
-91.8%
2,700
-90.5%
0.02%
-78.8%
Q4 2019$3,272,000
+73.9%
28,481
+90.8%
0.08%
+45.5%
Q3 2019$1,882,000
-26.9%
14,925
-30.3%
0.06%
-39.6%
Q2 2019$2,575,000
-69.9%
21,400
-78.1%
0.09%
-69.4%
Q1 2019$8,567,000
-8.7%
97,926
+4.4%
0.30%
-17.7%
Q4 2018$9,385,000
+1722.3%
93,800
+1984.4%
0.36%
+1469.6%
Q3 2018$515,000
-93.0%
4,500
-94.5%
0.02%
-94.2%
Q2 2018$7,381,000
-48.5%
82,300
-58.0%
0.40%
-62.8%
Q1 2018$14,324,000
+32.0%
195,784
+4.8%
1.08%
+20.9%
Q4 2017$10,852,000
+27.7%
186,840
-1.3%
0.89%
+14.6%
Q3 2017$8,497,000
+5.6%
189,368
-7.1%
0.78%
-6.5%
Q2 2017$8,050,000
+53.0%
203,846
+57.1%
0.83%
+57.5%
Q1 2017$5,262,000
+106.1%
129,724
+104.3%
0.53%
+59.7%
Q4 2016$2,553,00063,5050.33%
Other shareholders
HAEMONETICS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders